At a price of $8.25
What about peons that hold the stock thinking "science is sound" and could have traded profits but instead held and then are left holding the bag on a failed drug?
I have a low cost basis ($4.25) on my first purchase and I will buy more if it dips back below $6.00 although that doesn't look likely based on the bullish technicals that I've described earlier. I think the IPO was at $7.00 so keep in mind it's still trading below its IPO price. If it breaks through 7's next week on volume, this has a shot at taking out the 52 week high of $9.21. If all goes well with the upcoming data, you won't see a $6.00 handle ever again. All depends on the data
All systems go: Expanding volume, picture perfect inverse head & shoulders break out as well as P&F Chart showing double top break out with $10.25 price objective. Adding on all substantial dips.
Yes, very nice inverse head and shoulders break out with expanding volume confirming the uptrend. P&F Chart shows double top break out with $10.25 price objective.
"This past year has been remarkable for Amedica and I'm pleased to see that momentum carry into 2015," What planet is this guy on? Stock at all time lows and he says it's been a remarkable year? lol Guess he doesn't realize that his job is to maximize shareholder value and not his own wallet through stock options. This is called "fleecing."
Don't under estimate what the liabilities could be if all of the 60 Minutes claims turn out to be true. It's already a commodity business and if they get hit with huge legal expenses, this could be serious trouble for their balance sheet. Just sayin: CAUTION is warranted.
Piper Jaffray reiterated "outperform" with a $20.00 price target today. Read my post for the analyst comments. It will recover. Just have to be patient.
Piper Jaffray analyst Michael Grondahl reiterated an Overweight rating on Ocwen Financial Corp (NYSE: OCN) while trimming his price target to $20.00 (from $25.00) after the company ached a $2.5M settlement with California over OCN's failure to provide information to its California regulators in a timely manner.
"We believe this settlement largely removes the risk of OCN's servicing license being suspended in California," Grondahl said. "We note that California is OCN's largest state exposure by UPB at $95B and 378.1K loans. Additionally, OCN was served a notice of default on its servicing for 119 of ~4200 trusts serviced by OCN. These 119 trusts currently represent only ~$10B in servicing (originally ~$82B). We believe it is incorrect to assume that the entire servicing book will declare an event of default and pull servicing as this would greatly increase foreclosure timelines and hurt both borrowers/bondholders."